{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-020003","form_type":"8-K","ticker":"GDRX","cik":"0001809519","company_name":"GoodRx Holdings, Inc.","filed_at":"2023-05-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.710180+00:00","generated_at":"2026-06-15T06:54:24.581829+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"GoodRx Q1 revenue $184M beats guidance; adjusted EBITDA $53.2M","bullets":["Revenue $184.0M exceeds guidance; adjusted EBITDA $53.2M (28.9% margin) also above range.","Net loss $3.3M includes $25.5M stock-based comp; adjusted net income $29.5M (16.0% margin).","Scott Wagner appointed Interim CEO; Trevor Bezdek remains Chairman; leadership aims to accelerate growth.","Over 450,000 prescribers engaged via Provider Mode; over 7M consumers of prescription offerings.","Operating cash flow $32.3M in Q1 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-020003","json":"https://secwatch.observer/filing/0000950170-23-020003.json","markdown":"https://secwatch.observer/filing/0000950170-23-020003.md","text":"https://secwatch.observer/filing/0000950170-23-020003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1809519/000095017023020003/0000950170-23-020003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1809519/000095017023020003/gdrx-20230510.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T06:54:24.581829+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b1b2dc87a280c376c2217d412567071d29e16b42","claim":"GoodRx Holdings, Inc. reported the three months ended March 31, 2023 results: revenue $184.0 million, net income $3.3 million.","evidence_excerpt":"or the “Company”) , a leading digital healthcare platform, has released its financial results for the first quarter 2023. First Quarter 2023 Highlights • Total revenue of $184.0 million, exceeding previously announced guidance • Net loss of $3.3 million 1 ; Net loss margin of 1.8% • Adjusted Net Income 2 of $29.5 million; Adjusted Net Income Margin 2 of 16.0% •","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1809519/000095017023020003/0000950170-23-020003-index.htm","confidence":0.85,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended March 31, 2023"},{"label":"Revenue","value":"$184.0 million"},{"label":"Net income","value":"$3.3 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}